Literature DB >> 22909994

Nanocarriers for topical administration of resveratrol: a comparative study.

Immacolata Scognamiglio1, Daniela De Stefano, Virginia Campani, Laura Mayol, Rosa Carnuccio, Gabriella Fabbrocini, Fabio Ayala, Maria Immacolata La Rotonda, Giuseppe De Rosa.   

Abstract

The trans-resveratrol (t-res), a non-flavonoid polyphenol extracted from different plants, has recently earned interest for application on the skin for different applications. In this work, the potential of nanocarriers, namely transfersomes and ethanol-containing vesicles, to deliver t-res into/through the skin was investigated. Thus, transfersomes with different surfactants, namely polysorbate 80 (Tw80), sodium cholate (SC) and sodium deossicholate (SDC) and ethanol-containing vesicles with different lipid composition, namely soy phosphatidylcholine (SPC) and cholesterol (chol), encapsulating t-res were prepared and characterized. The nanocarriers had a mean diameter ranging between 83 and 116 nm with a high t-res encapsulation efficiency (≥ 70%). Moreover, cytotoxicity as well as the inhibition of production of reactive oxygen species (ROS) and lipid peroxidation, following incubation of H(2)O(2)-stimulated human keratinocyte (HaCaT) with t-res, as free or encapsulated into the nanocarriers, were investigated. Only blank nanocarriers containing Tw80 or ethanol were cytotoxic and led to increase of ROS, but this effect was not observed when using nanocarriers encapsulating t-res. Finally, permeation studies on porcine skin carried out on Franz diffusion cells, showed that only ethanol-containing vesicles based SPC were able to promote t-res permeation through the skin.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22909994     DOI: 10.1016/j.ijpharm.2012.08.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  32 in total

1.  A combination therapy of nanoethosomal piroxicam formulation along with iontophoresis as an anti-inflammatory transdermal delivery system for wound healing.

Authors:  Mostafa Kazemi; Reza Mombeiny; Shima Tavakol; Peyman Keyhanvar; Kazem Mousavizadeh
Journal:  Int Wound J       Date:  2019-08-08       Impact factor: 3.315

Review 2.  Human skin models: From healthy to disease-mimetic systems; characteristics and applications.

Authors:  Tânia Moniz; Sofia A Costa Lima; Salette Reis
Journal:  Br J Pharmacol       Date:  2020-08-19       Impact factor: 8.739

3.  Nanocarriers to Enhance the Accumulation of Vitamin K1 into the Skin.

Authors:  Virginia Campani; Marco Biondi; Laura Mayol; Francesco Cilurzo; Silvia Franzé; Michele Pitaro; Giuseppe De Rosa
Journal:  Pharm Res       Date:  2015-11-30       Impact factor: 4.200

4.  Formulation and Characterization of Cinnarizine Targeted Aural Transfersomal Gel for Vertigo Treatment: A Pharmacokinetic Study on Rabbits.

Authors:  Rehab Abdelmonem; Raghda Rabe Hamed; Sally A Abdelhalim; Mohamed F ElMiligi; Mohamed A El-Nabarawi
Journal:  Int J Nanomedicine       Date:  2020-08-19

5.  Ethosome-Derived Invasomes as a Potential Transdermal Delivery System for Vardenafil Hydrochloride: Development, Optimization and Application of Physiologically Based Pharmacokinetic Modeling in Adults and Geriatrics.

Authors:  Hussein O Ammar; Mina Ibrahim Tadros; Nahla M Salama; Amira Mohsen Ghoneim
Journal:  Int J Nanomedicine       Date:  2020-08-06

Review 6.  Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations.

Authors:  Ana Cláudia Paiva-Santos; Ana Luísa Silva; Catarina Guerra; Diana Peixoto; Miguel Pereira-Silva; Mahdi Zeinali; Filipa Mascarenhas-Melo; Ricardo Castro; Francisco Veiga
Journal:  Pharm Res       Date:  2021-05-25       Impact factor: 4.200

7.  Bilosomes as Promising Nanovesicular Carriers for Improved Transdermal Delivery: Construction, in vitro Optimization, ex vivo Permeation and in vivo Evaluation.

Authors:  Sadek Ahmed; Mohamed Aly Kassem; Sinar Sayed
Journal:  Int J Nanomedicine       Date:  2020-12-08

Review 8.  Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.

Authors:  Ana M Martins; Andreia Ascenso; Helena Margarida Ribeiro; Joana Marto
Journal:  Mol Neurobiol       Date:  2020-02-15       Impact factor: 5.590

9.  Novel rhein-phospholipid complex targeting skin diseases: development, in vitro, ex vivo, and in vivo studies.

Authors:  Heba M K Ebada; Maha M A Nasra; Yosra S R Elnaggar; Ossama Y Abdallah
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

10.  Improvement of Butamben Anesthetic Efficacy by the Development of Deformable Liposomes Bearing the Drug as Cyclodextrin Complex.

Authors:  Paola Mura; Francesca Maestrelli; Marzia Cirri; Giulia Nerli; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Natascia Mennini
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.